| 
 
 Session 
            Speaker 
 Potential antiasthmatic substances from antiasthmatic "jamu" 
            ingredient legundi leaves (vitex trifolia l.)
 Subagus – Wahyuono, Gemini Alam, Zullies Ikawati, 
            H. Timmerman, Kazutaka Maeyama
 
 "JAMU", Indonesian traditional medicine preparations 
            have been utilized extensively by Indonesian People. JAMU preparations 
            usually consists more than one plant parts ingredient, and there are 
            10 plant species commonly present in the JAMU intended to treat respiratory 
            disorders. Due to lack of scientific and clinical data, JAMU has not 
            been recommended for formal medication although it has been practiced 
            years before recorded history. Therefore, this study was initiated 
            by screening those plant materials (0.25 and 0.50 mg/ml, n=3) using 
            tracheospasmolytic activity in vitro (induced by histamine 10-7-10-3 
            M). The promising plant materials obtained was studied further to 
            determine the active compounds and their activity mechanisms. The 
            leaves of Vitex trifolia was among the most promising material, was 
            then taken for further studied.
 
 By Bioassay Guided Isolation, 3 compounds were isolated from the leaves 
            of V. trifolia and identified as Viteosin-A (1), Vitexicarpin (2) 
            and Vitetrifolin-E (3) based on their spectroscopic and literatures 
            data. Compound 2 was the strongest compared to that of 1 and 3, including 
            in a tracheospasmolytic test using sensitized (ovalbumin 5, 50, 500, 
            5000 ng/ml, n=3) guinea pig trachea. These compounds were not harmful 
            to organ as it was proved by inducing the organ after the test with 
            carbachol, followed by induction with saturated KCl. Their mechanism 
            seems to be antagonist non-competitive to the agonist used (histamine), 
            and are possibly able to stabilize the mast cells membrane function. 
            Upon testing of those compounds (1 x 10-4 M) on RBL-2H3 (Rat Basophilic 
            Leukemia cells represent mucosal mast cells) induced by DNA-BSA (Dinitrophenylated 
            Bovine Serum Albumin), compound 2 still showed the strongest to inhibit 
            the histamine release from RBL-2H3 compared to that of 1 and 3.
 
 
 
 
 |